The impact of a pilot continuing professional development module on hospital pharmacists’ preparedness to provide contemporary advice on the clinical use of vancomycin

SpringerPlus

Volumn 5, Issue 1, 2016, Pages

  Phillips, Cameron J ^a,b,c   Wisdom, Alice J ^a   Eaton, Vaughn S ^a,b,c   Woodman, Richard J ^b,d   McKinnon, Ross A ^b,c  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^d FLINDERS UNIVERSITY   (Australia)

Author keywords

Antibiotic; Confidence; Continuing education; Continuing professional development; Knowledge; Vancomycin

Indexed keywords

EID: 84961138459     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/s40064-016-1966-2     Document Type: Article

References (38)

1. Ang HG, Pua YH, Subari NA (2013) Mandatory continuing professional education in pharmacy: the Singapore experience. Int J Clin Pharm 35:570–576
2. Antibiotic Expert Group (2010) Therapeutic guidelines antibiotic version 14. Therapeutic Guidelines Limited, North Melbourne
3. Australian Health Practitioners Regulation Agency (2014) Code of conduct for registered health practitoners. Canberra, ACT
4. Awaisu A, Bakdach D, Elajez RH et al (2015) Hospital pharmacists’ self-evaluation of their competence and confidence in conducting pharmacy practice research. Saudi Pharm J 23:257–265
5. Bauters T, Claus B, Schelstraete P et al (2012) Vancomycin-induced red man syndrome in pediatric oncology: Still an issue? Int J Clin Pharm 34:13–16
6. Casebeer L, Brown J, Roepke N et al (2010) Evidence-based choices of physicians: a comparative analysis of physicians participating in Internet CME and non-participants. BMC Med Edu 10:42
7. Cervero RM, Gaines JK (2015) The impact of CME on physician performance and patient health outcomes: an updated synthesis of systematic reviews. J Contin Educ Health Prof 35:131–138
8. Charpentier MM, Orr KK, Taveira TH (2012) Improving pharmacist knowledge of oral chemotherapy in the community. Ann Pharmacother 46:1205–1211
9. Donyai P, Herbert RZ, Denicolo PM et al (2011) British pharmacy professionals’ beliefs and participation in continuing professional development: a review of the literature. Int J Pharm Pract 19:290–317
10. Driesen A, Verbeke K, Simoens S et al (2007) International trends in lifelong learning for pharmacists. Am J Pharm Educ 71:52
11. Fahimi F, Ariapanah P, Faizi M et al (2008) Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: an observational study. Aust Crit Care 21:110–116
12. Flodgren G, Parmelli E, Doumit G et al (2011) Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (8):CD000125. doi:10.1002/14651858.CD000125.pub4
13. Garrelts J, Peterie J (1985) Vancomycin and the “red man’s syndrome. N Engl J Med 312:245
14. Grzeskowiak LE, Thomas AE, To J et al (2015) Enhancing continuing education activities using audience response systems: a single-blind controlled trial. J Contin Educ Health Prof 35:38–45
15. Hoefel HH, Lautert L, Schmitt C et al (2008) Vancomycin administration: mistakes made by nursing staff. Nurs Stand 22:35–42
16. Hoelen DWM, Tjan DHT, van Vugt R et al (2007) Severe local vancomycin induced skin necrosis. Br J Clin Pharmacol 64:553–554
17. International Pharmaceutical Federation (2002) FIP statement of professional standards continuing professional development. FIP, The Hague
18. Karch AM (2012) 2013 Lippincott’s nursing drug guide. Lippincott Williams & Wilkins, Philadelphia
19. Likert R (1932) A technique for the measurement of attitudes. Arch Psychol 22:1–55
20. Lilley LL, Guanci R (1995) Red man syndrome. Am J Nur 95:14
21. Lomaestro BM (2011) Vancomycin dosing and monitoring 2 years after the guidelines. Expert Rev Anti Infect Ther 9:657–667
22. McMahon GT (2015) Advancing continuing medical education. JAMA 314:561–562
23. Morrison AP, Melanson SE, Carty MG et al (2012) What proportion of vancomycin trough levels are drawn too early? Frequency and impact on clinical actions. Am J Clin Pathol 137:472–478
24. Peacock J, Peacock P (2011) Oxford handbook of medical statistics. Oxford University Press, Oxford
25. Pharmaceutical Society of Australia (2010) The national competency framework for pharmacists in Australia Deakin, Australian Capital Territory
26. Pharmacy Board of Australia (2010) Guidelines on continuing professional development. Pharmacy Board of Australia, Canberra
27. Power A, Johnson BJ, Diack HL et al (2008) Scottish pharmacists’ views and attitudes towards continuing professional development. Pharm World Sci 30:136–143
28. Power A, Grammatiki A, Bates I et al (2011) Factors affecting the views and attitudes of Scottish pharmacists to continuing professional development. Int J Pharm Pract 19:424–430
29. Rosenthal M, Austin Z, Tsuyuki RT (2010) Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J 143:37–42
30. Rybak M, Lomaestro B, Rotschafer JC et al (2009a) Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 66:82–98
31. Rybak MJ, Lomaestro BM, Rotschafer JC et al (2009b) Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 49:325–327
32. Rybak MJ, Rotschafer JC, Rodvold KA (2013) Vancomycin: over 50 years later and still a work in progress. Pharmacother 33:1253–1255
33. Sivagnanam S, Deleu D (2003) Red man syndrome. Crit Care 7:119–120
34. The Society of Hospital Pharmacists of Australia (2012) SHPA CODE of ethics. The Society of Hospital Pharmacists of Australia, Collingwood
35. Tofade T, Duggan C, Rouse M et al (2015) The responsibility of advancing continuing professional development and continuing education globally. Am J Pharm Educ 79:16
36. Wallace MR, Mascola JR, Oldfield EC (1991) Red man syndrome: incidence, etiology, and prophylaxis. J Infect Dis 164:1180–1185
37. Wilson J, Estes L (2011) Mayo clinic antimicrobial therapy. Oxford University Press, Oxford
38. Yu T, Stockmann C, Balch AH et al (2014) Evolution of interventional vancomycin trials in light of new antibiotic development in the USA, 1999–2012. Int J Antimicrob Agents 43:215–222